Decibel Therapeutics, Inc. Quarterly Debt-to-equity in % from Q3 2021 to Q2 2023

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Decibel Therapeutics, Inc. quarterly Debt-to-equity history and growth rate from Q3 2021 to Q2 2023.
  • Decibel Therapeutics, Inc. Debt-to-equity for the quarter ending June 30, 2023 was 55.9 %, a 80.5% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2023 55.9 +24.9 +80.5% Jun 30, 2023
Q1 2023 48.3 +23.5 +94.9% Mar 31, 2023
Q4 2022 42.8 +22.9 +115% Dec 31, 2022
Q3 2022 37.7 +12.2 +47.9% Sep 30, 2022
Q2 2022 31 Jun 30, 2022
Q1 2022 24.8 Mar 31, 2022
Q4 2021 19.9 Dec 31, 2021
Q3 2021 25.5 Sep 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.